Supply Chain Council of European Union | Scceu.org
Distribution

FDA, companies add 3 heartburn meds to recall amid cancer concerns

FDA, companies add 3 heartburn meds to recall amid cancer concerns

A sample of NDMA, an impurity that has been linked to an increased risk for colorectal and uterine cancers, was found in samples of ranitidine, a drug used to treat and prevent heartburn by reducing stomach acid. It’s sold under the brand name Zantac. Valisure, a small pharmacy that checks the composition of drugs, and is responsible for the world-wide recall of the heartburn drug Zantac. (Stan Godlewski /The Washington Post via Getty Images)

Related posts

Douglas strong out of taxable sales gate

scceu

Coffee Holding Q1 2022 loss widens despite higher sales

scceu

Lynch Group IPO up and running, brokers send reports

scceu